报价延迟最少15分钟:2025/11/15 01:10 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
74.15 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
2.41/5.00
|
|
企业价值
19.12B
|
| 资产负债 |
|
每股账面净值
22.68
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
4.86B
|
|
每股收益
18.14
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/11/15 01:10 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
